ArticleFrontiers in cardiovascular medicine2026
Case Report: Type B intramural aortic hematoma: conservative management or early intervention? A case of rapid progression to aortic dissection.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Intramural hematoma (IMH) is a variant of acute aortic syndrome (AAS) with a highly variable and potentially life-threatening course. Although uncomplicated type B IMH is generally managed conservatively, early disease progression may occur despite optimal medical therapy. Thoracic endovascular aortic repair (TEVAR) represents a safe and effective treatment option in complicated cases, particularly when timely intervention is achieved. Case presentation: A 69-year-old woman presented with acute chest pain radiating to the back. CT angiography revealed a type B IMH extending from the aortic arch to the celiac trunk. The patient was initially managed medically under close surveillance. During hospitalization, she experienced recurrent chest pain and was incidentally diagnosed with a subsegmental pulmonary embolism, for which low-molecular-weight heparin was initiated Initial follow-up imaging showed no disease progression. However, on day 7, worsening symptoms prompted repeat CT, which demonstrated significant IMH progression with early signs of type B aortic dissection. Emergency TEVAR was successfully performed. The postoperative course was uneventful except for a transient post-implantation syndrome. Follow-up imaging confirmed good stent graft positioning and significant reduction of the hematoma. This case highlights the unpredictable evolution of type B IMH and emphasizes the importance of close clinical and radiological surveillance. It also illustrates the therapeutic dilemma posed by concomitant pulmonary embolism requiring anticoagulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.